Metraipolis › archive › dc_ee42d114ee15

Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI) — Europe PMC PMID:41467108

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41467108
DOI
10.1016/j.ctro.2025.101093
License (as archived)
solo-consultazione
Archived
2026-11-07T21:13:49.056Z
SHA-256 of the archived text
731c9b8ba5f932e2feaaeff174dc1639e2cecdddafa16061c30c9cde5b8d95e7
Stable URL of this page
https://metraipolis.com/documento/dc_ee42d114ee15

How to cite

Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI) — Europe PMC PMID:41467108 — Europe PMC (en), https://europepmc.org/article/MED/41467108 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee42d114ee15 (Metraipolis archive dc_ee42d114ee15, sha256 731c9b8ba5f932e2feaaeff174dc1639e2cecdddafa16061c30c9cde5b8d95e7)
BibTeX
@misc{dcee42d114ee15,
  title = {Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI) — Europe PMC PMID:41467108},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41467108},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee42d114ee15; sha256 731c9b8ba5f932e2feaaeff174dc1639e2cecdddafa16061c30c9cde5b8d95e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41467108. Agents can read the archived copy with the MCP tool read_document.